Is Celldex Therapeutics, Inc. (CLDX) a Smart Choice in Biotechnology Monday?

by InvestorsObserver, Benzinga Columnist
April 10, 2023 2:26 PM | 16 seconds read |
Celldex Therapeutics, Inc. (CLDX) is near the top in its industry group according to InvestorsObserver. CLDX gets an overall rating of 72. That means it scores higher than 72 percent of stocks. Celldex Therapeutics, Inc. gets a 88 rank in the Biotechnology industry. Biotechnology is number 38 out of 148 industries. CLDX ha
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!